Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Coya Therapeutics (COYA) Return on Capital Employed (2023 - 2025)

Coya Therapeutics' Return on Capital Employed history spans 3 years, with the latest figure at 0.71% for Q3 2025.

  • For Q3 2025, Return on Capital Employed fell 39.0% year-over-year to 0.71%; the TTM value through Sep 2025 reached 0.71%, down 39.0%, while the annual FY2024 figure was 0.44%, 4.0% down from the prior year.
  • Return on Capital Employed for Q3 2025 was 0.71% at Coya Therapeutics, up from 0.72% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.3% in Q1 2024 and bottomed at 1.03% in Q3 2023.
  • The 3-year median for Return on Capital Employed is 0.53% (2025), against an average of 0.58%.
  • The largest annual shift saw Return on Capital Employed soared 71bps in 2024 before it tumbled -42bps in 2025.
  • A 3-year view of Return on Capital Employed shows it stood at 0.37% in 2023, then tumbled by -30bps to 0.48% in 2024, then plummeted by -48bps to 0.71% in 2025.
  • Per Business Quant, the three most recent readings for COYA's Return on Capital Employed are 0.71% (Q3 2025), 0.72% (Q2 2025), and 0.53% (Q1 2025).